Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998980744> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2998980744 endingPage "303" @default.
- W2998980744 startingPage "303" @default.
- W2998980744 abstract "<h3>Importance</h3> Podophyllotoxin is an antimitotic agent primarily used in the local treatment of anogenital warts. Data that enable the assessment of the fetal safety of podophyllotoxin use during pregnancy are lacking. <h3>Objective</h3> To investigate the association between local podophyllotoxin exposure during pregnancy and risk of adverse fetal outcomes. <h3>Design, Setting, and Participants</h3> This cohort study obtained individual-level pregnancy data from various nationwide registries in Denmark from the study period of January 1, 1997, through December 31, 2016, resulting in a cohort of 1 650 649 pregnancies. Pregnancies with multiple records on overlapping dates and pregnancy records with implausible or missing information on gestational age were excluded. Local podophyllotoxin–exposed pregnancies were compared with unexposed pregnancies and matched in a 1:10 ratio according to propensity scores on a wide set of baseline characteristics. Five distinct study cohorts were constructed, one for each outcome analysis. Sensitivity analyses included a comparison of podophyllotoxin-exposed pregnancies with pregnancies with podophyllotoxin use only before pregnancy onset. Data analyses were performed from April 27, 2019, to June 26, 2019. <h3>Exposures</h3> Filled prescription for local podophyllotoxin. <h3>Main Outcomes and Measures</h3> Primary outcomes were major birth defects and spontaneous abortions. Secondary outcomes were preterm births, small-for-gestational-age (SGA) size, and stillbirths. Logistic regression was used to estimate the prevalence odds ratios (ORs) of major birth defects, preterm births, and SGA size, and Cox proportional hazards regression modeling was used to estimate hazard ratios (HRs) of spontaneous abortions and stillbirths. <h3>Results</h3> This study included 9229 pregnancies (mean [SD] maternal age at pregnancy onset, 27.7 [5.2] years) for the analyses of major birth defects and 18 590 pregnancies (mean [SD] maternal age at pregnancy onset, 26.4 [6.0] years) for the analyses of spontaneous abortions. Among the podophyllotoxin-exposed pregnancies, 29 infants (3.5%) were diagnosed with major birth defects, compared with 286 (3.4%) among the unexposed pregnancies. A total of 141 podophyllotoxin-exposed pregnancies (8.3%) ended in spontaneous abortion, compared with 1626 (9.6%) among the unexposed pregnancies. No statistically significant associations were found between podophyllotoxin exposure during pregnancy and major birth defects (prevalence odds ratio [OR], 1.02 95% CI, 0.69-1.50), spontaneous abortions (HR, 0.87; 95% CI, 0.73-1.04), preterm births (prevalence OR, 1.08; 95% CI, 0.86-1.35), SGA size (prevalence OR, 1.01; 95% CI, 0.85-1.22), or stillbirths (HR, 0.58; 95% CI, 0.18-1.86). Sensitivity analyses of the primary outcomes achieved similar results. <h3>Conclusions and Relevance</h3> Findings from this study suggest that podophyllotoxin use during pregnancy may be safe, as it did not appear to be associated with an increased risk of adverse fetal outcomes. These findings may help guide clinicians, patients, and drug regulatory authorities when prescribing podophyllotoxin." @default.
- W2998980744 created "2020-01-23" @default.
- W2998980744 creator A5018745897 @default.
- W2998980744 creator A5086293022 @default.
- W2998980744 date "2020-03-01" @default.
- W2998980744 modified "2023-10-18" @default.
- W2998980744 title "Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During Pregnancy" @default.
- W2998980744 cites W1907956264 @default.
- W2998980744 cites W1984585202 @default.
- W2998980744 cites W2000991311 @default.
- W2998980744 cites W2011456563 @default.
- W2998980744 cites W2021708857 @default.
- W2998980744 cites W2024390368 @default.
- W2998980744 cites W2074628482 @default.
- W2998980744 cites W2102420102 @default.
- W2998980744 cites W2102924526 @default.
- W2998980744 cites W2142749836 @default.
- W2998980744 cites W2146635529 @default.
- W2998980744 cites W2255273619 @default.
- W2998980744 cites W2316420267 @default.
- W2998980744 cites W2329380270 @default.
- W2998980744 cites W2937470138 @default.
- W2998980744 cites W4233185668 @default.
- W2998980744 cites W4240278274 @default.
- W2998980744 cites W4240622609 @default.
- W2998980744 cites W4245561267 @default.
- W2998980744 cites W4245969539 @default.
- W2998980744 cites W4253103140 @default.
- W2998980744 cites W4254637496 @default.
- W2998980744 cites W4300652584 @default.
- W2998980744 cites W1984656597 @default.
- W2998980744 doi "https://doi.org/10.1001/jamadermatol.2019.4315" @default.
- W2998980744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6990942" @default.
- W2998980744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31913405" @default.
- W2998980744 hasPublicationYear "2020" @default.
- W2998980744 type Work @default.
- W2998980744 sameAs 2998980744 @default.
- W2998980744 citedByCount "6" @default.
- W2998980744 countsByYear W29989807442020 @default.
- W2998980744 countsByYear W29989807442021 @default.
- W2998980744 countsByYear W29989807442022 @default.
- W2998980744 countsByYear W29989807442023 @default.
- W2998980744 crossrefType "journal-article" @default.
- W2998980744 hasAuthorship W2998980744A5018745897 @default.
- W2998980744 hasAuthorship W2998980744A5086293022 @default.
- W2998980744 hasBestOaLocation W29989807441 @default.
- W2998980744 hasConcept C126322002 @default.
- W2998980744 hasConcept C131872663 @default.
- W2998980744 hasConcept C156957248 @default.
- W2998980744 hasConcept C201903717 @default.
- W2998980744 hasConcept C207103383 @default.
- W2998980744 hasConcept C2778279030 @default.
- W2998980744 hasConcept C2778376644 @default.
- W2998980744 hasConcept C2779234561 @default.
- W2998980744 hasConcept C2780938740 @default.
- W2998980744 hasConcept C44249647 @default.
- W2998980744 hasConcept C50382708 @default.
- W2998980744 hasConcept C54355233 @default.
- W2998980744 hasConcept C71924100 @default.
- W2998980744 hasConcept C86803240 @default.
- W2998980744 hasConceptScore W2998980744C126322002 @default.
- W2998980744 hasConceptScore W2998980744C131872663 @default.
- W2998980744 hasConceptScore W2998980744C156957248 @default.
- W2998980744 hasConceptScore W2998980744C201903717 @default.
- W2998980744 hasConceptScore W2998980744C207103383 @default.
- W2998980744 hasConceptScore W2998980744C2778279030 @default.
- W2998980744 hasConceptScore W2998980744C2778376644 @default.
- W2998980744 hasConceptScore W2998980744C2779234561 @default.
- W2998980744 hasConceptScore W2998980744C2780938740 @default.
- W2998980744 hasConceptScore W2998980744C44249647 @default.
- W2998980744 hasConceptScore W2998980744C50382708 @default.
- W2998980744 hasConceptScore W2998980744C54355233 @default.
- W2998980744 hasConceptScore W2998980744C71924100 @default.
- W2998980744 hasConceptScore W2998980744C86803240 @default.
- W2998980744 hasIssue "3" @default.
- W2998980744 hasLocation W29989807441 @default.
- W2998980744 hasLocation W29989807442 @default.
- W2998980744 hasLocation W29989807443 @default.
- W2998980744 hasOpenAccess W2998980744 @default.
- W2998980744 hasPrimaryLocation W29989807441 @default.
- W2998980744 hasRelatedWork W1965053403 @default.
- W2998980744 hasRelatedWork W2026094606 @default.
- W2998980744 hasRelatedWork W2037119342 @default.
- W2998980744 hasRelatedWork W2071306276 @default.
- W2998980744 hasRelatedWork W2347015317 @default.
- W2998980744 hasRelatedWork W2551708751 @default.
- W2998980744 hasRelatedWork W2611840721 @default.
- W2998980744 hasRelatedWork W2971892937 @default.
- W2998980744 hasRelatedWork W4310244857 @default.
- W2998980744 hasRelatedWork W4361773135 @default.
- W2998980744 hasVolume "156" @default.
- W2998980744 isParatext "false" @default.
- W2998980744 isRetracted "false" @default.
- W2998980744 magId "2998980744" @default.
- W2998980744 workType "article" @default.